Details for New Drug Application (NDA): 020080
✉ Email this page to a colleague
The generic ingredient in IMITREX STATDOSE is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.
Summary for 020080
Tradename: | IMITREX STATDOSE |
Applicant: | Glaxosmithkline |
Ingredient: | sumatriptan succinate |
Patents: | 0 |
Pharmacology for NDA: 020080
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Suppliers and Packaging for NDA: 020080
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
IMITREX | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 020080 | NDA | GlaxoSmithKline LLC | 0173-0478 | 0173-0478-00 | 2 SYRINGE in 1 CARTON (0173-0478-00) / .5 mL in 1 SYRINGE |
IMITREX | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 020080 | NDA | GlaxoSmithKline LLC | 0173-0479 | 0173-0479-00 | 2 SYRINGE in 1 PACKAGE (0173-0479-00) / .5 mL in 1 SYRINGE |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;SUBCUTANEOUS | Strength | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 28, 1992 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;SUBCUTANEOUS | Strength | EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML) | ||||
Approval Date: | Feb 1, 2006 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;SUBCUTANEOUS | Strength | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | ||||
Approval Date: | Dec 23, 1996 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 020080
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline | IMITREX | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 020080-001 | Dec 28, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | IMITREX STATDOSE | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 020080-003 | Dec 23, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | IMITREX STATDOSE | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 020080-003 | Dec 23, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | IMITREX STATDOSE | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 020080-002 | Feb 1, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | IMITREX | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 020080-001 | Dec 28, 1992 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription